GGrantIndex
← Leaderboards

Ashley Smuder

University Of Florida

$4,324,646
Attributed
$4,896,521
Total exposure
3
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY201923
$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$4,896,521 · 3

By mechanism

R01$4,896,521 · 3

Top collaborators

Most similar at University Of Florida

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Oxidation-Reduction

Research focus

Oxidation-ReductionProductionFoundationsAttenuatedPathologyMolecularAntisense OligonucleotidesAntioxidantsExperimental StudyUp-RegulationReactive Oxygen SpeciesRecombinant Adeno-Associated Virus (Raav)Oxidative StressExposure ToOverexpressionLeadFutureIronBiologicalCarrier ProteinsFree RadicalsConsensusAnti-CancerCytochrome C Reductase

Grant awards (14)

Doxorubicin-induced respiratory dysfunction and the protective effects of exercise$374,408
R01 · FY2023 · HL · contact PI
Doxorubicin cardiotoxicity and the protective effects of exercise$361,119
R01 · FY2023 · HL · contact PI
Hyperbaric oxygen therapy mitigates respiratoryneuromuscular pathology after spinal cord injury$381,250
R01 · FY2022 · HL
Doxorubicin-induced respiratory dysfunction and the protective effects of exercise$374,408
R01 · FY2022 · HL · contact PI
Doxorubicin cardiotoxicity and the protective effects of exercise$362,698
R01 · FY2022 · HL · contact PI
Doxorubicin cardiotoxicity and the protective effects of exercise$398,821
R01 · FY2021 · HL · contact PI
Hyperbaric oxygen therapy mitigates respiratoryneuromuscular pathology after spinal cord injury$381,250
R01 · FY2021 · HL
Doxorubicin-induced respiratory dysfunction and the protective effects of exercise$374,408
R01 · FY2021 · HL · contact PI
Hyperbaric oxygen therapy mitigates respiratoryneuromuscular pathology after spinal cord injury$381,250
R01 · FY2020 · HL
Doxorubicin-induced respiratory dysfunction and the protective effects of exercise$374,408
R01 · FY2020 · HL · contact PI
Doxorubicin cardiotoxicity and the protective effects of exercise$365,434
R01 · FY2020 · HL · contact PI
Doxorubicin cardiotoxicity and the protective effects of exercise$39,778
R01 · FY2020 · HL · contact PI
Doxorubicin cardiotoxicity and the protective effects of exercise$366,619
R01 · FY2019 · HL · contact PI
Doxorubicin-induced respiratory dysfunction and the protective effects of exercise$360,670
R01 · FY2019 · HL · contact PI